These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22197965)

  • 1. The phylogeny of yellow fever virus 17D vaccines.
    Stock NK; Boschetti N; Herzog C; Appelhans MS; Niedrig M
    Vaccine; 2012 Feb; 30(6):989-94. PubMed ID: 22197965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Completed sequences analysis on the Chinese attenuated yellow fever 17D vaccine strain and the WHO standard yellow fever 17D vaccine strain].
    Li J; Yu YX; Dong GM
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):145-51. PubMed ID: 20077661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the 17D-204 yellow fever vaccine.
    Salmona M; Gazaignes S; Mercier-Delarue S; Garnier F; Korimbocus J; Colin de Verdière N; LeGoff J; Roques P; Simon F
    Vaccine; 2015 Oct; 33(41):5432-5436. PubMed ID: 26314624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Characterization of Yellow Fever Virus Wild-Type Strain Asibi, Parent to Live-Attenuated 17D Vaccine, from Three Different Sources.
    Davis EH; Thompson JK; Widen SG; Barrett ADT
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.
    Pugachev KV; Ocran SW; Guirakhoo F; Furby D; Monath TP
    Vaccine; 2002 Jan; 20(7-8):996-9. PubMed ID: 11803058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing.
    Beck A; Tesh RB; Wood TG; Widen SG; Ryman KD; Barrett AD
    J Infect Dis; 2014 Feb; 209(3):334-44. PubMed ID: 24141982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium.
    Bae HG; Drosten C; Emmerich P; Colebunders R; Hantson P; Pest S; Parent M; Schmitz H; Warnat MA; Niedrig M
    J Clin Virol; 2005 Aug; 33(4):274-80. PubMed ID: 16036176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it.
    Jennings AD; Whitby JE; Minor PD; Barrett AD
    Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of yellow fever virus genomes from four imported cases in China.
    Cui S; Pan Y; Lyu Y; Liang Z; Li J; Sun Y; Dou X; Tian L; Huo D; Chen L; Li X; Wang Q
    Int J Infect Dis; 2017 Jul; 60():93-95. PubMed ID: 28623054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos.
    Marchevsky RS; da Luz Leal M; Homma A; Coutinho ES; Camacho LA; Jabor AV; Galler R; Freire MS
    Biologicals; 2006 Sep; 34(3):191-7. PubMed ID: 16326110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
    Bonaldo MC; Garratt RC; Freire MS; Galler R
    Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a new yellow fever virus lineage within the South American genotype I in Brazil.
    de Souza RP; Foster PG; Sallum MA; Coimbra TL; Maeda AY; Silveira VR; Moreno ES; da Silva FG; Rocco IM; Ferreira IB; Suzuki A; Oshiro FM; Petrella SM; Pereira LE; Katz G; Tengan CH; Siciliano MM; Dos Santos CL
    J Med Virol; 2010 Jan; 82(1):175-85. PubMed ID: 19950229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
    Engel AR; Vasconcelos PF; McArthur MA; Barrett AD
    Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.